Janus Henderson Group PLC lowered its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 2.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 160,689 shares of the medical research company’s stock after selling 4,492 shares during the period. Janus Henderson Group PLC’s holdings in IQVIA were worth $40,631,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. AdvisorNet Financial Inc boosted its stake in shares of IQVIA by 327.6% during the fourth quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock valued at $29,000 after acquiring an additional 95 shares during the last quarter. Rise Advisors LLC acquired a new position in shares of IQVIA in the first quarter valued at approximately $31,000. Riverview Trust Co purchased a new position in shares of IQVIA during the first quarter valued at approximately $32,000. Covestor Ltd grew its stake in IQVIA by 45.3% in the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock worth $39,000 after acquiring an additional 48 shares during the period. Finally, Security National Bank purchased a new position in shares of IQVIA during the 4th quarter worth $41,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.
IQVIA Stock Performance
Shares of NYSE:IQV traded up $3.19 on Wednesday, hitting $248.76. The company’s stock had a trading volume of 220,702 shares, compared to its average volume of 1,085,734. IQVIA Holdings Inc. has a 12 month low of $167.42 and a 12 month high of $261.73. The stock’s 50-day moving average is $220.70 and its two-hundred day moving average is $229.94. The company has a debt-to-equity ratio of 1.80, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $45.35 billion, a price-to-earnings ratio of 33.55, a price-to-earnings-growth ratio of 2.24 and a beta of 1.49.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on IQV shares. Evercore ISI upped their price objective on shares of IQVIA from $230.00 to $270.00 and gave the company an “outperform” rating in a research note on Tuesday, July 23rd. The Goldman Sachs Group began coverage on shares of IQVIA in a research note on Thursday, June 6th. They set a “buy” rating and a $270.00 price target on the stock. Truist Financial lifted their target price on IQVIA from $292.00 to $300.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Morgan Stanley raised their price objective on IQVIA from $270.00 to $280.00 and gave the stock an “overweight” rating in a report on Tuesday, July 23rd. Finally, Robert W. Baird raised their price target on shares of IQVIA from $235.00 to $251.00 and gave the company a “neutral” rating in a report on Tuesday, July 23rd. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $263.56.
About IQVIA
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Featured Articles
- Five stocks we like better than IQVIA
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Stock Splits, Do They Really Impact Investors?
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 5 Aggressive Growth Stocks for Long-Term Investors
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.